Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ARVN - Connecting The Dots: Are Pfizer And Arvinas At Work On A COVID Cure?

ARVN - Connecting The Dots: Are Pfizer And Arvinas At Work On A COVID Cure?

Arvinas Inc.
  • Arvinas went public at $16 on September 26, 2018. The stock zoomed to $92.77 on the early trial successes of its two oncology targets. and currently trades at $67.18.
  • Pfizer has a cooperation with Arvinas, which the latter shows may deliver another $802 million potential revenue.  Little has been said about this cooperation since its announcement.
  • Arvinas is a pioneer in using targeted protein degradation to cure various maladies.  Pfizer and their Covid vaccine partner BioNTech know all about the proteins involved in SARS CoV-2.
  • On May 19, 2021, the CEO of Arvinas competitor Progenra (private) gave a talk on using protein degradation for SARS-CoV-2. So protein degradation is definitely on the radar for SARS-CoV-2.

For further details see:

Connecting The Dots: Are Pfizer And Arvinas At Work On A COVID Cure?
Stock Information
Company Name: Arvinas Inc.
Stock Symbol: ARVN
Market: NASDAQ
Website: arvinas.com
Menu
ARVN ARVN Quote ARVN Short ARVN News ARVN Articles ARVN Message Board
Get ARVN Alerts

News, Short Squeeze, Breakout and More Instantly...